Despite recent progress, significant risks remain, leading me to stay on the sidelines regarding investment in Theravance. Explore more details here.

Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) had its price objective lowered by Piper Sandler from $10.00 to $6.00 in ...

Stock analysts at StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Q4 2024 Earnings Call Transcript March 6, 2025 Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

AGC Biologics wins award for top CDMO in both the "Biologics - Global" and "Cell and Gene - Global" categories in annual CDMO Leadership Awards.

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

While the job market is tough for life sciences professionals right now, it won’t always be. Employers must continue striving ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

We recently compiled a list of the 10 Most Undervalued US Stocks to Buy According to Hedge Funds. In this article, we are ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...